Publications Archive - KalVista Pharmaceuticals

Presentations & Publications

We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.

Apply Reset

Topic

Forum

Year

Apply Reset

Showing 2 out of 2

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.

Simao F, Ustunkaya T, Clermont AC, and Feener EP.
Blood. 2017.
PMID:28130211

The kallikrein-kinin system in diabetic retinopathy: Lessons for the kidney.

Phipps JA and Feener EP.
Kidney Int., 2008;73(10):1114-9.
PMID:18272958

About